Gracell Biotechnologies Inc. GRCL
Set alert
10.25 +10.25 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 989.87M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -56.94
- Beta
- -0.34
- Short ratio
- 0.87
- Inst. own
- 63.11%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 11, 2024
- 50-d avg
- 9.54
- 200-d avg
- 5.24
- 1y target
- 10.58
Discussion (5)
Sign in to join the discussion
Ahmad Meehrab GRCL 4 years ago #1I am expecting 15+ today
Ahmad Meehrab GRCL 4 years ago #2We will see 12 today and like LGvN we will see 40+ in after hours
Ahmad Meehrab GRCL 4 years ago #3Price target is 45.
Just like I told you all about KTtA yesterday it will go 300%
Joel Rypstra GRCL 4 years ago #4Get in $OCGN for the run next. Who approved now FDA approval coming .
Canada approval any day.
Hedge arsonist GRCL 5 years ago #5Buy $TYME. Hear me out. New ceo and 100m share offering. Same week they patent covid oral cure. cup and handle is being formed. Reason for red day. Past 3.18 this will blast multiples. Please do your dad and thank me later.
P.s. the new ceo of TYME is the one the ceo that sold the current cure to Pfizer. So........